TOP CATEGORY: Chemicals & Materials | Life Sciences | Banking & Finance | ICT Media

Global Colorectal Cancer Therapeutics Market Research Report 2023

Global Colorectal Cancer Therapeutics Market Research Report 2023

  • Category:Life Sciences
  • Published on : 16 December 2022
  • Pages :97
  • Formats:
  • Report Code:SMR-7512373
OfferClick for best price

Best Price: $2320

Colorectal Cancer Therapeutics Market Size, Share 2022


Market Analysis and Insights: Global Colorectal Cancer Therapeutics Market

The global Colorectal Cancer Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Colorectal Cancer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Colorectal Cancer Therapeutics market in terms of revenue.

On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Colorectal Cancer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Colorectal Cancer Therapeutics market.

Global Colorectal Cancer Therapeutics Scope and Market Size

Market Analysis and Insights: Global Colorectal Cancer Therapeutics Market

Colorectal cancer (CRC), also known as bowel cancer and colon cancer, is the development of cancer from the colon or rectum (parts of the large intestine). A cancer is the abnormal growth of cells that have the ability to invade or spread to other parts of the body. Signs and symptoms may include blood in the stool, a change in bowel movements, weight loss, and feeling tired all the time

The global Colorectal Cancer Therapeutics market size is projected to reach US$ 17070 million by 2030, from US$ 12130 million in 2022, at a CAGR of 4.9% during 2023-2030.

Fully considering the economic change by this health crisis, Diagnostics accounting for % of the Colorectal Cancer Therapeutics global market in 2022, is projected to value US$ million by 2030, growing at a revised % CAGR from 2023 to 2030. While Hospitals segment is altered to an % CAGR throughout this forecast period.

China Colorectal Cancer Therapeutics market size is valued at US$ million in 2022, while the North America and Europe Colorectal Cancer Therapeutics are US$ million and US$ million, severally. The proportion of the North America is % in 2022, while China and Europe are % and respectively, and it is predicted that China proportion will reach % in 2030, trailing a CAGR of % through the analysis period 2023-2030. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Colorectal Cancer Therapeutics landscape, Germany is projected to reach US$ million by 2030 trailing a CAGR of % over the forecast period 2023-2030.

With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Colorectal Cancer Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Colorectal Cancer Therapeutics market in terms of revenue.

Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Colorectal Cancer Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Colorectal Cancer Therapeutics market.

Global Colorectal Cancer Therapeutics Scope and Market Size

Colorectal Cancer Therapeutics market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Colorectal Cancer Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2030.

Segment by Type

Diagnostics

Therapeutics

Segment by Application

Hospitals

Clinic

Research Institutions

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

By Company

Taiho Pharma

Merck KGaA

Amgen

Takeda

Roche

Eli Lilly

Sanofi

Regeneron

Bayer

Onyx

Bristol-Myers Squib

Sumitomo Dainippon Pharma

Array BioPharma

Hutchison MediPharma

Jiangsu Hengrui Medicine

Jiangsu Chia-Tai Tianqing

Suzhou Zelgen Biopharmaceuticals

The information for each competitor/Company Profile includes:

  • Company Overview
  • Business Strategy
  • Key Product Offerings
  • Financial Performance
  • Key Performance Indicators
  • Risk Analysis
  • Recent Development
  • Regional Presence
  • SWOT Analysis 

The content of the study subjects includes a total of 15 chapters:

Chapter 1, describes Colorectal Cancer Therapeutics product scope, market overview, market opportunities, market driving force, and market risks.

Chapter 2, profiles the top manufacturers of Colorectal Cancer Therapeutics, with price, sales, revenue, and global market share of Colorectal Cancer Therapeutics from 2019 to 2022.

Chapter 3, the Colorectal Cancer Therapeutics competitive situation, sales, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.

Chapter 4, the Colorectal Cancer Therapeutics breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2017 to 2028.

Chapters 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, and application, from 2017 to 2028.

Chapters 7, 8, 9, 10, and 11, to break the sales data at the country level, with sales, revenue, and market share for key countries in the world, from 2017 to 2022. and the Colorectal Cancer Therapeutics market forecast, by regions, type, and application, with sales and revenue, from 2023 to 2028.

Chapter 12, the key raw materials and key suppliers, and industry chain of Colorectal Cancer Therapeutics.

Chapter 13, 14, and 15, to describe Colorectal Cancer Therapeutics sales channel, distributors, customers, research findings and conclusion, appendix and data source.

Key Indicators Analysed:

  • Market Players & Competitor Analysis: The report covers the key players of the industry including Company Profile, Product Specifications, Production Capacity/Sales, Revenue, Price and Gross Margin 2016-2027 & Sales with a thorough analysis of the market?s competitive landscape and detailed information on vendors and comprehensive details of factors that will challenge the growth of major market vendors.
  • Global and Regional Market Analysis: The report includes Global & Regional market status and outlook 2016-2027. Further the report provides break down details about each region & countries covered in the report. Identifying its sales, sales volume & revenue forecast. With detailed analysis by types and applications.
  • Market Trends: Market key trends which include Increased Competition and Continuous Innovations.
  • Opportunities and Drivers: Identifying the Growing Demands and New Technology
  • Porters Five Force Analysis: The report provides with the state of competition in industry depending on five basic forces: threat of new entrants, bargaining power of suppliers, bargaining power of buyers, threat of substitute products or services, and existing industry rivalry.

Reasons to Purchase this Report:

  • Estimates 2022-2027 2021-2025 Colorectal Cancer Therapeutics Report on, Status and Forecast, by Players, Types and Applications market development trends with the recent trends and SWOT analysis
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • Market segmentation analysis including qualitative and quantitative research incorporating the impact of economic and policy aspects
  • Regional and country level analysis integrating the demand and supply forces that are influencing the growth of the market.
  • Market value (USD Million) and volume (Units Million) data for each segment and sub-segment
  • Competitive landscape involving the market share of major players, along with the new projects and strategies adopted by players in the past five years
  • Comprehensive company profiles covering the product offerings, key financial information, recent developments, SWOT analysis, and strategies employed by the major market players
  • 1-year analyst support, along with the data support in excel format.

Research Methodology:

The research methodology used to estimate and forecast this market begins by capturing the revenues of the key players and their shares in the market. Various secondary sources such as press releases, annual reports, non-profit organizations, industry associations, governmental agencies and customs data, have been used to identify and collect information useful for this extensive commercial study of the market. Calculations based on this led to the overall market size. After arriving at the overall market size, the total market has been split into several segments and subsegments, which have then been verified through primary research by conducting extensive interviews with industry experts such as CEOs, VPs, directors, and executives. The data triangulation and market breakdown procedures have been employed to complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments.

Report Attributes Report Details
Report Title Global Colorectal Cancer Therapeutics Market Research Report 2023
Historical Year 2018 to 2022 (Data from 2010 can be provided as per availability)
Base Year 2021
Forecast Year 2029
Number of Pages 97 Pages
Customization Available Yes, the report can be customized as per your need.

TABLE OF CONTENTS

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Colorectal Cancer Therapeutics Market Size Growth Rate by Type: 2018 VS 2022 VS 2030
1.2.2 Diagnostics
1.2.3 Therapeutics
1.3 Market by Application
1.3.1 Global Colorectal Cancer Therapeutics Market Share by Application: 2018 VS 2022 VS 2030
1.3.2 Hospitals
1.3.3 Clinic
1.3.4 Research Institutions
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Colorectal Cancer Therapeutics Market Perspective (2018-2030)
2.2 Colorectal Cancer Therapeutics Growth Trends by Region
2.2.1 Colorectal Cancer Therapeutics Market Size by Region: 2018 VS 2022 VS 2030
2.2.2 Colorectal Cancer Therapeutics Historic Market Size by Region (2018-2023)
2.2.3 Colorectal Cancer Therapeutics Forecasted Market Size by Region (2023-2030)
2.3 Colorectal Cancer Therapeutics Market Dynamics
2.3.1 Colorectal Cancer Therapeutics Industry Trends
2.3.2 Colorectal Cancer Therapeutics Market Drivers
2.3.3 Colorectal Cancer Therapeutics Market Challenges
2.3.4 Colorectal Cancer Therapeutics Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Colorectal Cancer Therapeutics Players by Revenue
3.1.1 Global Top Colorectal Cancer Therapeutics Players by Revenue (2018-2023)
3.1.2 Global Colorectal Cancer Therapeutics Revenue Market Share by Players (2018-2023)
3.2 Global Colorectal Cancer Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Colorectal Cancer Therapeutics Revenue
3.4 Global Colorectal Cancer Therapeutics Market Concentration Ratio
3.4.1 Global Colorectal Cancer Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Colorectal Cancer Therapeutics Revenue in 2022
3.5 Colorectal Cancer Therapeutics Key Players Head office and Area Served
3.6 Key Players Colorectal Cancer Therapeutics Product Solution and Service
3.7 Date of Enter into Colorectal Cancer Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Colorectal Cancer Therapeutics Breakdown Data by Type
4.1 Global Colorectal Cancer Therapeutics Historic Market Size by Type (2018-2023)
4.2 Global Colorectal Cancer Therapeutics Forecasted Market Size by Type (2023-2030)
5 Colorectal Cancer Therapeutics Breakdown Data by Application
5.1 Global Colorectal Cancer Therapeutics Historic Market Size by Application (2018-2023)
5.2 Global Colorectal Cancer Therapeutics Forecasted Market Size by Application (2023-2030)
6 North America
6.1 North America Colorectal Cancer Therapeutics Market Size (2018-2030)
6.2 North America Colorectal Cancer Therapeutics Market Size by Country (2018-2023)
6.3 North America Colorectal Cancer Therapeutics Market Size by Country (2023-2030)
6.4 United States
6.5 Canada
7 Europe
7.1 Europe Colorectal Cancer Therapeutics Market Size (2018-2030)
7.2 Europe Colorectal Cancer Therapeutics Market Size by Country (2018-2023)
7.3 Europe Colorectal Cancer Therapeutics Market Size by Country (2023-2030)
7.4 Germany
7.5 France
7.6 U.K.
7.7 Italy
7.8 Russia
7.9 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Colorectal Cancer Therapeutics Market Size (2018-2030)
8.2 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Country (2018-2023)
8.3 Asia-Pacific Colorectal Cancer Therapeutics Market Size by Country (2023-2030)
8.4 China
8.5 Japan
8.6 South Korea
8.7 Southeast Asia
8.8 India
8.9 Australia
9 Latin America
9.1 Latin America Colorectal Cancer Therapeutics Market Size (2018-2030)
9.2 Latin America Colorectal Cancer Therapeutics Market Size by Country (2018-2023)
9.3 Latin America Colorectal Cancer Therapeutics Market Size by Country (2023-2030)
9.4 Mexico
9.5 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Colorectal Cancer Therapeutics Market Size (2018-2030)
10.2 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country (2018-2023)
10.3 Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country (2023-2030)
10.4 Turkey
10.5 Saudi Arabia
10.6 UAE
11 Key Players Profiles
11.1 Taiho Pharma
11.1.1 Taiho Pharma Company Detail
11.1.2 Taiho Pharma Business Overview
11.1.3 Taiho Pharma Colorectal Cancer Therapeutics Introduction
11.1.4 Taiho Pharma Revenue in Colorectal Cancer Therapeutics Business (2018-2023)
11.1.5 Taiho Pharma Recent Development
11.2 Merck KGaA
11.2.1 Merck KGaA Company Detail
11.2.2 Merck KGaA Business Overview
11.2.3 Merck KGaA Colorectal Cancer Therapeutics Introduction
11.2.4 Merck KGaA Revenue in Colorectal Cancer Therapeutics Business (2018-2023)
11.2.5 Merck KGaA Recent Development
11.3 Amgen
11.3.1 Amgen Company Detail
11.3.2 Amgen Business Overview
11.3.3 Amgen Colorectal Cancer Therapeutics Introduction
11.3.4 Amgen Revenue in Colorectal Cancer Therapeutics Business (2018-2023)
11.3.5 Amgen Recent Development
11.4 Takeda
11.4.1 Takeda Company Detail
11.4.2 Takeda Business Overview
11.4.3 Takeda Colorectal Cancer Therapeutics Introduction
11.4.4 Takeda Revenue in Colorectal Cancer Therapeutics Business (2018-2023)
11.4.5 Takeda Recent Development
11.5 Roche
11.5.1 Roche Company Detail
11.5.2 Roche Business Overview
11.5.3 Roche Colorectal Cancer Therapeutics Introduction
11.5.4 Roche Revenue in Colorectal Cancer Therapeutics Business (2018-2023)
11.5.5 Roche Recent Development
11.6 Eli Lilly
11.6.1 Eli Lilly Company Detail
11.6.2 Eli Lilly Business Overview
11.6.3 Eli Lilly Colorectal Cancer Therapeutics Introduction
11.6.4 Eli Lilly Revenue in Colorectal Cancer Therapeutics Business (2018-2023)
11.6.5 Eli Lilly Recent Development
11.7 Sanofi
11.7.1 Sanofi Company Detail
11.7.2 Sanofi Business Overview
11.7.3 Sanofi Colorectal Cancer Therapeutics Introduction
11.7.4 Sanofi Revenue in Colorectal Cancer Therapeutics Business (2018-2023)
11.7.5 Sanofi Recent Development
11.8 Regeneron
11.8.1 Regeneron Company Detail
11.8.2 Regeneron Business Overview
11.8.3 Regeneron Colorectal Cancer Therapeutics Introduction
11.8.4 Regeneron Revenue in Colorectal Cancer Therapeutics Business (2018-2023)
11.8.5 Regeneron Recent Development
11.9 Bayer
11.9.1 Bayer Company Detail
11.9.2 Bayer Business Overview
11.9.3 Bayer Colorectal Cancer Therapeutics Introduction
11.9.4 Bayer Revenue in Colorectal Cancer Therapeutics Business (2018-2023)
11.9.5 Bayer Recent Development
11.10 Onyx
11.10.1 Onyx Company Detail
11.10.2 Onyx Business Overview
11.10.3 Onyx Colorectal Cancer Therapeutics Introduction
11.10.4 Onyx Revenue in Colorectal Cancer Therapeutics Business (2018-2023)
11.10.5 Onyx Recent Development
11.11 Bristol-Myers Squib
11.11.1 Bristol-Myers Squib Company Detail
11.11.2 Bristol-Myers Squib Business Overview
11.11.3 Bristol-Myers Squib Colorectal Cancer Therapeutics Introduction
11.11.4 Bristol-Myers Squib Revenue in Colorectal Cancer Therapeutics Business (2018-2023)
11.11.5 Bristol-Myers Squib Recent Development
11.12 Sumitomo Dainippon Pharma
11.12.1 Sumitomo Dainippon Pharma Company Detail
11.12.2 Sumitomo Dainippon Pharma Business Overview
11.12.3 Sumitomo Dainippon Pharma Colorectal Cancer Therapeutics Introduction
11.12.4 Sumitomo Dainippon Pharma Revenue in Colorectal Cancer Therapeutics Business (2018-2023)
11.12.5 Sumitomo Dainippon Pharma Recent Development
11.13 Array BioPharma
11.13.1 Array BioPharma Company Detail
11.13.2 Array BioPharma Business Overview
11.13.3 Array BioPharma Colorectal Cancer Therapeutics Introduction
11.13.4 Array BioPharma Revenue in Colorectal Cancer Therapeutics Business (2018-2023)
11.13.5 Array BioPharma Recent Development
11.14 Hutchison MediPharma
11.14.1 Hutchison MediPharma Company Detail
11.14.2 Hutchison MediPharma Business Overview
11.14.3 Hutchison MediPharma Colorectal Cancer Therapeutics Introduction
11.14.4 Hutchison MediPharma Revenue in Colorectal Cancer Therapeutics Business (2018-2023)
11.14.5 Hutchison MediPharma Recent Development
11.15 Jiangsu Hengrui Medicine
11.15.1 Jiangsu Hengrui Medicine Company Detail
11.15.2 Jiangsu Hengrui Medicine Business Overview
11.15.3 Jiangsu Hengrui Medicine Colorectal Cancer Therapeutics Introduction
11.15.4 Jiangsu Hengrui Medicine Revenue in Colorectal Cancer Therapeutics Business (2018-2023)
11.15.5 Jiangsu Hengrui Medicine Recent Development
11.16 Jiangsu Chia-Tai Tianqing
11.16.1 Jiangsu Chia-Tai Tianqing Company Detail
11.16.2 Jiangsu Chia-Tai Tianqing Business Overview
11.16.3 Jiangsu Chia-Tai Tianqing Colorectal Cancer Therapeutics Introduction
11.16.4 Jiangsu Chia-Tai Tianqing Revenue in Colorectal Cancer Therapeutics Business (2018-2023)
11.16.5 Jiangsu Chia-Tai Tianqing Recent Development
11.17 Suzhou Zelgen Biopharmaceuticals
11.17.1 Suzhou Zelgen Biopharmaceuticals Company Detail
11.17.2 Suzhou Zelgen Biopharmaceuticals Business Overview
11.17.3 Suzhou Zelgen Biopharmaceuticals Colorectal Cancer Therapeutics Introduction
11.17.4 Suzhou Zelgen Biopharmaceuticals Revenue in Colorectal Cancer Therapeutics Business (2018-2023)
11.17.5 Suzhou Zelgen Biopharmaceuticals Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

LIST OF TABLES & FIGURES

List of Tables
Table 1. Global Colorectal Cancer Therapeutics Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2030
Table 2. Key Players of Diagnostics
Table 3. Key Players of Therapeutics
Table 4. Global Colorectal Cancer Therapeutics Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2030
Table 5. Global Colorectal Cancer Therapeutics Market Size by Region (US$ Million): 2018 VS 2022 VS 2030
Table 6. Global Colorectal Cancer Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 7. Global Colorectal Cancer Therapeutics Market Share by Region (2018-2023)
Table 8. Global Colorectal Cancer Therapeutics Forecasted Market Size by Region (2023-2030) & (US$ Million)
Table 9. Global Colorectal Cancer Therapeutics Market Share by Region (2023-2030)
Table 10. Colorectal Cancer Therapeutics Market Trends
Table 11. Colorectal Cancer Therapeutics Market Drivers
Table 12. Colorectal Cancer Therapeutics Market Challenges
Table 13. Colorectal Cancer Therapeutics Market Restraints
Table 14. Global Colorectal Cancer Therapeutics Revenue by Players (2018-2023) & (US$ Million)
Table 15. Global Colorectal Cancer Therapeutics Market Share by Players (2018-2023)
Table 16. Global Top Colorectal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Therapeutics as of 2022)
Table 17. Ranking of Global Top Colorectal Cancer Therapeutics Companies by Revenue (US$ Million) in 2022
Table 18. Global 5 Largest Players Market Share by Colorectal Cancer Therapeutics Revenue (CR5 and HHI) & (2018-2023)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Colorectal Cancer Therapeutics Product Solution and Service
Table 21. Date of Enter into Colorectal Cancer Therapeutics Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Colorectal Cancer Therapeutics Market Size by Type (2018-2023) & (US$ Million)
Table 24. Global Colorectal Cancer Therapeutics Revenue Market Share by Type (2018-2023)
Table 25. Global Colorectal Cancer Therapeutics Forecasted Market Size by Type (2023-2030) & (US$ Million)
Table 26. Global Colorectal Cancer Therapeutics Revenue Market Share by Type (2023-2030)
Table 27. Global Colorectal Cancer Therapeutics Market Size by Application (2018-2023) & (US$ Million)
Table 28. Global Colorectal Cancer Therapeutics Revenue Market Share by Application (2018-2023)
Table 29. Global Colorectal Cancer Therapeutics Forecasted Market Size by Application (2023-2030) & (US$ Million)
Table 30. Global Colorectal Cancer Therapeutics Revenue Market Share by Application (2023-2030)
Table 31. North America Colorectal Cancer Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 32. North America Colorectal Cancer Therapeutics Market Size by Country (2023-2030) & (US$ Million)
Table 33. Europe Colorectal Cancer Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 34. Europe Colorectal Cancer Therapeutics Market Size by Country (2023-2030) & (US$ Million)
Table 35. Asia-Pacific Colorectal Cancer Therapeutics Market Size by Region (2018-2023) & (US$ Million)
Table 36. Asia-Pacific Colorectal Cancer Therapeutics Market Size by Region (2023-2030) & (US$ Million)
Table 37. Latin America Colorectal Cancer Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 38. Latin America Colorectal Cancer Therapeutics Market Size by Country (2023-2030) & (US$ Million)
Table 39. Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country (2018-2023) & (US$ Million)
Table 40. Middle East & Africa Colorectal Cancer Therapeutics Market Size by Country (2023-2030) & (US$ Million)
Table 41. Taiho Pharma Company Detail
Table 42. Taiho Pharma Business Overview
Table 43. Taiho Pharma Colorectal Cancer Therapeutics Product
Table 44. Taiho Pharma Revenue in Colorectal Cancer Therapeutics Business (2018-2023) & (US$ Million)
Table 45. Taiho Pharma Recent Development
Table 46. Merck KGaA Company Detail
Table 47. Merck KGaA Business Overview
Table 48. Merck KGaA Colorectal Cancer Therapeutics Product
Table 49. Merck KGaA Revenue in Colorectal Cancer Therapeutics Business (2018-2023) & (US$ Million)
Table 50. Merck KGaA Recent Development
Table 51. Amgen Company Detail
Table 52. Amgen Business Overview
Table 53. Amgen Colorectal Cancer Therapeutics Product
Table 54. Amgen Revenue in Colorectal Cancer Therapeutics Business (2018-2023) & (US$ Million)
Table 55. Amgen Recent Development
Table 56. Takeda Company Detail
Table 57. Takeda Business Overview
Table 58. Takeda Colorectal Cancer Therapeutics Product
Table 59. Takeda Revenue in Colorectal Cancer Therapeutics Business (2018-2023) & (US$ Million)
Table 60. Takeda Recent Development
Table 61. Roche Company Detail
Table 62. Roche Business Overview
Table 63. Roche Colorectal Cancer Therapeutics Product
Table 64. Roche Revenue in Colorectal Cancer Therapeutics Business (2018-2023) & (US$ Million)
Table 65. Roche Recent Development
Table 66. Eli Lilly Company Detail
Table 67. Eli Lilly Business Overview
Table 68. Eli Lilly Colorectal Cancer Therapeutics Product
Table 69. Eli Lilly Revenue in Colorectal Cancer Therapeutics Business (2018-2023) & (US$ Million)
Table 70. Eli Lilly Recent Development
Table 71. Sanofi Company Detail
Table 72. Sanofi Business Overview
Table 73. Sanofi Colorectal Cancer Therapeutics Product
Table 74. Sanofi Revenue in Colorectal Cancer Therapeutics Business (2018-2023) & (US$ Million)
Table 75. Sanofi Recent Development
Table 76. Regeneron Company Detail
Table 77. Regeneron Business Overview
Table 78. Regeneron Colorectal Cancer Therapeutics Product
Table 79. Regeneron Revenue in Colorectal Cancer Therapeutics Business (2018-2023) & (US$ Million)
Table 80. Regeneron Recent Development
Table 81. Bayer Company Detail
Table 82. Bayer Business Overview
Table 83. Bayer Colorectal Cancer Therapeutics Product
Table 84. Bayer Revenue in Colorectal Cancer Therapeutics Business (2018-2023) & (US$ Million)
Table 85. Bayer Recent Development
Table 86. Onyx Company Detail
Table 87. Onyx Business Overview
Table 88. Onyx Colorectal Cancer Therapeutics Product
Table 89. Onyx Revenue in Colorectal Cancer Therapeutics Business (2018-2023) & (US$ Million)
Table 90. Onyx Recent Development
Table 91. Bristol-Myers Squib Company Detail
Table 92. Bristol-Myers Squib Business Overview
Table 93. Bristol-Myers Squib Colorectal Cancer TherapeuticsProduct
Table 94. Bristol-Myers Squib Revenue in Colorectal Cancer Therapeutics Business (2018-2023) & (US$ Million)
Table 95. Bristol-Myers Squib Recent Development
Table 96. Sumitomo Dainippon Pharma Company Detail
Table 97. Sumitomo Dainippon Pharma Business Overview
Table 98. Sumitomo Dainippon Pharma Colorectal Cancer TherapeuticsProduct
Table 99. Sumitomo Dainippon Pharma Revenue in Colorectal Cancer Therapeutics Business (2018-2023) & (US$ Million)
Table 100. Sumitomo Dainippon Pharma Recent Development
Table 101. Array BioPharma Company Detail
Table 102. Array BioPharma Business Overview
Table 103. Array BioPharma Colorectal Cancer TherapeuticsProduct
Table 104. Array BioPharma Revenue in Colorectal Cancer Therapeutics Business (2018-2023) & (US$ Million)
Table 105. Array BioPharma Recent Development
Table 106. Hutchison MediPharma Company Detail
Table 107. Hutchison MediPharma Business Overview
Table 108. Hutchison MediPharma Colorectal Cancer TherapeuticsProduct
Table 109. Hutchison MediPharma Revenue in Colorectal Cancer Therapeutics Business (2018-2023) & (US$ Million)
Table 110. Hutchison MediPharma Recent Development
Table 111. Jiangsu Hengrui Medicine Company Detail
Table 112. Jiangsu Hengrui Medicine Business Overview
Table 113. Jiangsu Hengrui Medicine Colorectal Cancer TherapeuticsProduct
Table 114. Jiangsu Hengrui Medicine Revenue in Colorectal Cancer Therapeutics Business (2018-2023) & (US$ Million)
Table 115. Jiangsu Hengrui Medicine Recent Development
Table 116. Jiangsu Chia-Tai Tianqing Company Detail
Table 117. Jiangsu Chia-Tai Tianqing Business Overview
Table 118. Jiangsu Chia-Tai Tianqing Colorectal Cancer TherapeuticsProduct
Table 119. Jiangsu Chia-Tai Tianqing Revenue in Colorectal Cancer Therapeutics Business (2018-2023) & (US$ Million)
Table 120. Jiangsu Chia-Tai Tianqing Recent Development
Table 121. Suzhou Zelgen Biopharmaceuticals Company Detail
Table 122. Suzhou Zelgen Biopharmaceuticals Business Overview
Table 123. Suzhou Zelgen Biopharmaceuticals Colorectal Cancer TherapeuticsProduct
Table 124. Suzhou Zelgen Biopharmaceuticals Revenue in Colorectal Cancer Therapeutics Business (2018-2023) & (US$ Million)
Table 125. Suzhou Zelgen Biopharmaceuticals Recent Development
Table 126. Research Programs/Design for This Report
Table 127. Key Data Information from Secondary Sources
Table 128. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Colorectal Cancer Therapeutics Market Share by Type: 2022 VS 2030
Figure 2. Diagnostics Features
Figure 3. Therapeutics Features
Figure 4. Global Colorectal Cancer Therapeutics Market Share by Application in 2022 & 2030
Figure 5. Hospitals Case Studies
Figure 6. Clinic Case Studies
Figure 7. Research Institutions Case Studies
Figure 8. Colorectal Cancer Therapeutics Report Years Considered
Figure 9. Global Colorectal Cancer Therapeutics Market Size (US$ Million), Year-over-Year: 2018-2030
Figure 10. Global Colorectal Cancer Therapeutics Market Size, (US$ Million), 2018 VS 2022 VS 2030
Figure 11. Global Colorectal Cancer Therapeutics Market Share by Region: 2022 VS 2030
Figure 12. Global Colorectal Cancer Therapeutics Market Share by Players in 2022
Figure 13. Global Top Colorectal Cancer Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Colorectal Cancer Therapeutics as of 2022)
Figure 14. The Top 10 and 5 Players Market Share by Colorectal Cancer Therapeutics Revenue in 2022
Figure 15. North America Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 16. North America Colorectal Cancer Therapeutics Market Share by Country (2018-2030)
Figure 17. United States Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 18. Canada Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 19. Europe Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 20. Europe Colorectal Cancer Therapeutics Market Share by Country (2018-2030)
Figure 21. Germany Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 22. France Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 23. U.K. Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 24. Italy Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 25. Russia Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 26. Nordic Countries Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 27. Asia-Pacific Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 28. Asia-Pacific Colorectal Cancer Therapeutics Market Share by Region (2018-2030)
Figure 29. China Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 30. Japan Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 31. South Korea Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 32. Southeast Asia Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 33. India Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 34. Australia Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 35. Latin America Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 36. Latin America Colorectal Cancer Therapeutics Market Share by Country (2018-2030)
Figure 37. Mexico Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 38. Brazil Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 39. Middle East & Africa Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 40. Middle East & Africa Colorectal Cancer Therapeutics Market Share by Country (2018-2030)
Figure 41. Turkey Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 42. Saudi Arabia Colorectal Cancer Therapeutics Market Size YoY Growth (2018-2030) & (US$ Million)
Figure 43. Taiho Pharma Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2018-2023)
Figure 44. Merck KGaA Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2018-2023)
Figure 45. Amgen Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2018-2023)
Figure 46. Takeda Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2018-2023)
Figure 47. Roche Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2018-2023)
Figure 48. Eli Lilly Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2018-2023)
Figure 49. Sanofi Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2018-2023)
Figure 50. Regeneron Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2018-2023)
Figure 51. Bayer Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2018-2023)
Figure 52. Onyx Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2018-2023)
Figure 53. Bristol-Myers Squib Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2018-2023)
Figure 54. Sumitomo Dainippon Pharma Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2018-2023)
Figure 55. Array BioPharma Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2018-2023)
Figure 56. Hutchison MediPharma Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2018-2023)
Figure 57. Jiangsu Hengrui Medicine Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2018-2023)
Figure 58. Jiangsu Chia-Tai Tianqing Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2018-2023)
Figure 59. Suzhou Zelgen Biopharmaceuticals Revenue Growth Rate in Colorectal Cancer Therapeutics Business (2018-2023)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed

REPORT PURCHASE OPTIONS

USD Single User Price
USD Multi User Price
USD Enterprise Price

---- OR ----

Frequently Asked Questions ?

  • Upto 24 hrs - Working days
  • Upto 48 hrs max - Weekends and public holidays
  • Single User License
    A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.

  • Multi user License
    A license granted to multiple users.

  • Site License
    A license granted to a single business site/establishment.

  • Corporate License, Global License
    A license granted to all employees within organisation access to the product.
  • Online Payments with PayPal and CCavenue
  • Wire Transfer/Bank Transfer
  • Email
  • Hard Copy

Our Key Features

  • Data Accuracy and Reliability
  • Data Security
  • Customized Research
  • Trustworthy
  • Competitive Offerings
check discount